Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#332 most reported symptom for this vaccine
Blood alkaline phosphatase increased has been reported 24 times in association with DTaP + Hepatitis B + IPV (Pediarix) vaccination in VAERS. This represents 0.2% of all 15,041 reports for this vaccine.
Among these reports, 2 mentioned death (8.33%) and 21 involved hospitalization (87.5%).
Blood alkaline phosphatase increased is the #332 most frequently reported symptom for DTaP + Hepatitis B + IPV (Pediarix) out of 1275 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 24 reports of Blood alkaline phosphatase increased after DTaP + Hepatitis B + IPV (Pediarix) vaccination may seem alarming, but context is critical.
The 8.33% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.